£1.33m
−9%vs Dec 2024Active12373627Private limited companyCardiff
MARIPOSA THERAPEUTICS LIMITED
Significant control: Timothy Calvin Hafner (25–50%), Lucas Maximilian Hafner (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mariposa Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Mariposa Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
MARIPOSA THERAPEUTICS LIMITED is an active private limited company (company number 12373627) incorporated on 20 December 2019, registered in Cardiff. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £1.33m and cash of £29, with 4 employees on average. Net assets fell 9% on the prior period (£1.46m).
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Mr Timothy Calvin Hafner
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Lucas Maximilian Hafner
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Neem Biotech Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- Ctl Familienstiftung
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 20 December 20196 yrs ago
- Next accounts due
- 30 September 2027in 336 days
- Confirmation statement due
- 3 January 2027in 66 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£29
−99%vs Dec 2024Not reported
4
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £1.33m | £29 | — | £41k | — | — | 4 |
| 31 December 2024 | £1.46m | £3,813 | — | £40k | — | — | 4 |
Current ratio0.09Current assets ÷ creditors within one year
Cash per employee£7Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,325,035 at 31 December 2025
- Current assets below creditors within one yearCurrent ratio 0.09
- Incorporated five or more years agoIncorporated 20 December 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 336 days
- Confirmation statement duein 66 days
- Accounts period endNet assets £1.33m · small accounts
- Accounts period endNet assets £1.46m · small accounts
- Incorporated
08
Similar companies in Cardiff
09
Reminders for MARIPOSA THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.